Literature DB >> 28096201

Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?

Leticia M Nogueira1,2, Christina C Newton3, Michael Pollak4, Debra T Silverman2, Demetrius Albanes2, Satu Männistö5, Stephanie J Weinstein2, Eric J Jacobs6, Rachael Z Stolzenberg-Solomon7.   

Abstract

Background: Studies examining associations between circulating concentrations of C-peptide and total adiponectin, two biomarkers related to obesity and insulin secretion and sensitivity and pancreatic ductal adenocarcinoma (PDA) risk have shown inconsistent results and included limited numbers of smokers.
Methods: We examined associations of these biomarkers and high molecular weight (HMW) adiponectin with PDA, overall, and by smoking status. We conducted a pooled nested case-control analysis in 3 cohorts (Prostate, Lung, Colorectal, and Ovarian Cancer Trial, Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, and Cancer Prevention Study-II), with 758 cases (435 current smokers) and 1,052 controls (531 smokers) matched by cohort, age, sex, race, blood draw date and follow-up time. We used conditional logistic regression adjusted for age, smoking, diabetes, and body mass index to calculate ORs and 95% confidence intervals (CI).
Results: Circulating C-peptide concentration was not associated with PDA in never or former smokers, but was inversely associated with PDA in current smokers (per SD OR = 0.67; 95% CI, 0.54-0.84; Pinteraction = 0.005). HMW adiponectin was inversely associated with PDA in never smokers (OR = 0.43; 95% CI, 0.23-0.81), not associated in former smokers, and positively associated in smokers (OR = 1.23; 95% CI, 1.04-1.45; Pinteraction = 0.009). Total adiponectin was not associated with PDA in nonsmokers or current smokers.Conclusions: Associations of biomarkers of insulin secretion and sensitivity with PDA differ by smoking status. Smoking-induced pancreatic damage may explain the associations in smokers while mechanisms related to insulin resistance associations in nonsmokers.Impact: Future studies of these biomarkers and PDA should examine results by smoking status. Cancer Epidemiol Biomarkers Prev; 26(6); 914-22. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28096201      PMCID: PMC5457333          DOI: 10.1158/1055-9965.EPI-16-0891

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  41 in total

Review 1.  Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer.

Authors:  Eric J Duell
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Flexible regression models with cubic splines.

Authors:  S Durrleman; R Simon
Journal:  Stat Med       Date:  1989-05       Impact factor: 2.373

Review 3.  Adiponectin as a routine clinical biomarker.

Authors:  Ken Kishida; Tohru Funahashi; Iichiro Shimomura
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-08-20       Impact factor: 4.690

4.  The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort.

Authors:  Verena A Grote; Sabine Rohrmann; Laure Dossus; Alexandra Nieters; Jytte Halkjaer; Anne Tjønneland; Kim Overvad; Jakob Stegger; Nathalie Chabbert-Buffet; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Birgit Teucher; Susen Becker; Jukka Montonen; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Sabina Sieri; Rosario Tumino; Paolo Vineis; Amalia Mattiello; Marcial Argüelles; Eric J Duell; Esther Molina-Montes; Nerea Larrañaga; María-Dolores Chirlaque; Aurelio Barricarte Gurrea; Suzanne M Jeurnink; Petra Hm Peeters; Weimin Ye; Malin Sund; Björn Lindkvist; Dorthe Johansen; Kay-Tee Khaw; Nick Wareham; Francesca L Crowe; Isabelle Romieu; Sabina Rinaldi; Mazda Jenab; Dora Romaguera; Dominique S Michaud; Elio Riboli; H Bas Bueno-de-Mesquita; Rudolf Kaaks
Journal:  Int J Cancer       Date:  2011-09-17       Impact factor: 7.396

5.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics.

Authors:  Eugenia E Calle; Carmen Rodriguez; Eric J Jacobs; M Lyn Almon; Ann Chao; Marjorie L McCullough; Heather S Feigelson; Michael J Thun
Journal:  Cancer       Date:  2002-05-01       Impact factor: 6.860

6.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

7.  Determinants of serum adiponectin in persons with and without type 1 diabetes.

Authors:  David M Maahs; Lorraine G Ogden; Janet K Snell-Bergeon; Gregory L Kinney; R Paul Wadwa; John E Hokanson; Dana Dabelea; Adam Kretowski; Robert H Eckel; Marian Rewers
Journal:  Am J Epidemiol       Date:  2007-06-24       Impact factor: 4.897

8.  A pooled analysis of body mass index and pancreatic cancer mortality in african americans.

Authors:  Traci N Bethea; Cari M Kitahara; Jennifer Sonderman; Alpa V Patel; Chinonye Harvey; Synnøve F Knutsen; Yikyung Park; Song Yi Park; Gary E Fraser; Eric J Jacobs; Mark P Purdue; Rachael Z Stolzenberg-Solomon; Elizabeth M Gillanders; William J Blot; Julie R Palmer; Laurence N Kolonel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-13       Impact factor: 4.254

Review 9.  Cigarette smoke-induced pancreatic damage: experimental data.

Authors:  Uwe A Wittel; Ulrich T Hopt; Surinder K Batra
Journal:  Langenbecks Arch Surg       Date:  2008-01-12       Impact factor: 3.445

Review 10.  The clinical utility of C-peptide measurement in the care of patients with diabetes.

Authors:  A G Jones; A T Hattersley
Journal:  Diabet Med       Date:  2013-07       Impact factor: 4.359

View more
  3 in total

Review 1.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

2.  Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3.

Authors:  Evelina Mocci; Prosenjit Kundu; Nilanjan Chatterjee; Alison P Klein; Rachael Stolzenberg-Solomon; William Wheeler; Alan A Arslan; Laura E Beane-Freeman; Paige M Bracci; Paul Brennan; Federico Canzian; Mengmeng Du; Steven Gallinger; Graham G Giles; Phyllis J Goodman; Charles Kooperberg; Loic Le Marchand; Rachel E Neale; Xiao-Ou Shu; Kala Visvanathan; Emily White; Wei Zheng; Demetrius Albanes; Gabriella Andreotti; Ana Babic; William R Bamlet; Sonja I Berndt; Amanda L Blackford; Bas Bueno-de-Mesquita; Julie E Buring; Daniele Campa; Stephen J Chanock; Erica J Childs; Eric J Duell; Charles S Fuchs; J Michael Gaziano; Edward L Giovannucci; Michael G Goggins; Patricia Hartge; Manal M Hassan; Elizabeth A Holly; Robert N Hoover; Rayjean J Hung; Robert C Kurtz; I-Min Lee; Núria Malats; Roger L Milne; Kimmie Ng; Ann L Oberg; Salvatore Panico; Ulrike Peters; Miquel Porta; Kari G Rabe; Elio Riboli; Nathaniel Rothman; Ghislaine Scelo; Howard D Sesso; Debra T Silverman; Victoria L Stevens; Oliver Strobel; Ian M Thompson; Anne Tjonneland; Antonia Trichopoulou; Stephen K Van Den Eeden; Jean Wactawski-Wende; Nicolas Wentzensen; Lynne R Wilkens; Herbert Yu; Fangcheng Yuan; Anne Zeleniuch-Jacquotte; Laufey T Amundadottir; Donghui Li; Eric J Jacobs; Gloria M Petersen; Brian M Wolpin; Harvey A Risch; Peter Kraft
Journal:  Cancer Res       Date:  2021-02-11       Impact factor: 13.312

Review 3.  Obesity and Pancreatic Cancer: Insight into Mechanisms.

Authors:  Guido Eibl; Enrique Rozengurt
Journal:  Cancers (Basel)       Date:  2021-10-10       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.